Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Tepezza
The U.S. launch date for Tepezza (teprotumumab-trgb) was February 3, 2020 [1]. It received Food and Drug Administration (FDA) approval on January 21, 2020 [2].
Other Questions About Tepezza :